Skip to main content
SpringerLink
Log in
Book cover

Stroke Revisited: Vascular Cognitive Impairment pp 15–24Cite as

Post-stroke Cognitive Impairment

  • Chapter
  • First Online:

Part of the book series: Stroke Revisited ((STROREV))

Abstract

Post-stroke cognitive impairment (PSCI) is a leading cause of vascular cognitive impairment. The clinical presentation of PSCI varies according to the location and size of the stroke lesion. Despite having a significant effect on functional recovery after stroke, the PSCI is relatively less of the focus than hyperacute stroke management including intra-arterial thrombectomy. In this chapter, we summarize the research conducted so far on the epidemiology, classification, clinical characteristics, and neuropsychological evaluations of PSCI. In addition, we provide insights on the way neuroimaging studies could improve the understanding of the mechanisms underlying cognitive impairment following stroke. Finally, we highlight that although many disappointing outcomes in therapeutic trials are still present, various collaborative research efforts to overcome the existing limitations are expected in the future.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Satizabal CL, Beiser AS, Chouraki V, et al. Incidence of dementia over three decades in the Framingham heart study. N Engl J Med. 2016;374(6):523–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–18.

    Article  PubMed  Google Scholar 

  3. Liu W, Wong A, Au L, et al. Influence of amyloid-beta on cognitive decline after stroke/transient ischemic attack: three-year longitudinal study. Stroke. 2015;46(11):3074–80.

    Article  CAS  PubMed  Google Scholar 

  4. Wollenweber FA, Zietemann V, Rominger A, et al. The determinants of dementia after stroke (DEDEMAS) study: protocol and pilot data. Int J Stroke. 2014;9(3):387–92.

    Article  PubMed  Google Scholar 

  5. Yang J, Wong A, Wang Z, et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement. 2015;11(1):16–23.

    Article  PubMed  Google Scholar 

  6. Dong Y, Sharma VK, Chan BP, et al. The Montreal cognitive assessment (MoCA) is superior to the mini-mental state examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci. 2010;299(1–2):15–8.

    Article  PubMed  Google Scholar 

  7. Moulin S, Labreuche J, Bombois S, et al. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol. 2016;15(8):820–9.

    Article  PubMed  Google Scholar 

  8. Mok VC, Lam BY, Wong A, et al. Early-onset and delayed-onset poststroke dementia—revisiting the mechanisms. Nat Rev Neurol. 2017;13(3):148–59.

    Article  PubMed  Google Scholar 

  9. Jack CR Jr, Bennett DA, Blennow K, et al. A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87(5):539–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. del Ser T, Barba R, Morin MM, et al. Evolution of cognitive impairment after stroke and risk factors for delayed progression. Stroke. 2005;36(12):2670–5.

    Article  PubMed  Google Scholar 

  11. Levine DA, Galecki AT, Langa KM, et al. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314(1):41–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Pendlebury ST, Markwick A, de Jager CA, et al. Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA. Cerebrovasc Dis. 2012;34(1):48–54.

    Article  CAS  PubMed  Google Scholar 

  13. Zietemann V, Georgakis MK, Dondaine T, et al. Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke. Neurology. 2018;91(20):e1838–50.

    Article  PubMed  Google Scholar 

  14. Lim JS, Oh MS, Lee JH, et al. Prediction of post-stroke dementia using NINDS-CSN 5-minute neuropsychology protocol in acute stroke. Int Psychogeriatr. 2017;29(5):777–84.

    Article  PubMed  Google Scholar 

  15. Wong A, Nyenhuis D, Black SE, et al. Montreal cognitive assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration. Stroke. 2015;46(4):1059–64.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672–713.

    Article  PubMed  PubMed Central  Google Scholar 

  17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, Inc.; 2013.

    Book  Google Scholar 

  18. Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Hachinski V, Iadecola C, Petersen RC, et al. National institute of neurological disorders and stroke-Canadian stroke network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220–41.

    Article  PubMed  Google Scholar 

  20. Lim JS, Noh M, Kim BJ, et al. A methodological perspective on the longitudinal cognitive change after stroke. Dement Geriatr Cogn Disord. 2017;44(5–6):311–9.

    Article  PubMed  Google Scholar 

  21. Pendlebury ST, Chen PJ, Welch SJ, et al. Methodological factors in determining risk of dementia after transient ischemic attack and stroke: (II) effect of attrition on follow-up. Stroke. 2015;46(6):1494–500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Zhao L, Biesbroek JM, Shi L, et al. Strategic infarct location for post-stroke cognitive impairment: a multivariate lesion-symptom mapping study. J Cereb Blood Flow Metab. 2018;38(8):1299–311.

    Article  PubMed  Google Scholar 

  23. Duering M, Righart R, Csanadi E, et al. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology. 2012;79(20):2025–8.

    Article  PubMed  Google Scholar 

  24. Alstott J, Breakspear M, Hagmann P, et al. Modeling the impact of lesions in the human brain. PLoS Comput Biol. 2009;5(6):e1000408.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Lim JS, Kim N, Jang MU, et al. Cortical hubs and subcortical cholinergic pathways as neural substrates of poststroke dementia. Stroke. 2014;45(4):1069–76.

    Article  PubMed  Google Scholar 

  26. Siegel JS, Ramsey LE, Snyder AZ, et al. Disruptions of network connectivity predict impairment in multiple behavioral domains after stroke. Proc Natl Acad Sci U S A. 2016;113(30):E4367–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Siegel JS, Seitzman BA, Ramsey LE, et al. Re-emergence of modular brain networks in stroke recovery. Cortex. 2018;101:44–59.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol. 2018;17(11):1016–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Sahathevan R, Linden T, Villemagne VL, et al. Positron emission tomographic imaging in stroke: cross-sectional and follow-up assessment of amyloid in ischemic stroke. Stroke. 2016;47(1):113–9.

    Article  CAS  PubMed  Google Scholar 

  30. Cho SH, Cho H, Park S, et al. Increased uptake of AV-1451 in a subacute infarction lesion. Yonsei Med J. 2018;59(4):563–5.

    Article  PubMed  PubMed Central  Google Scholar 

  31. van der Flier WM, Skoog I, Schneider JA, et al. Vascular cognitive impairment. Nat Rev Dis Primers. 2018;4:18003.

    Article  PubMed  Google Scholar 

  32. Diener HC, Sacco RL, Yusuf S, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for effectively avoiding second strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008;7(10):875–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Pearce LA, McClure LA, Anderson DC, et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol. 2014;13(12):1177–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kim BJ, Lee EJ, Kwon SU, et al. Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial. Lancet Neurol. 2018;17(6):509–18.

    Article  PubMed  Google Scholar 

  35. Yu KH, Hong KS, Oh MS, et al. Design and rationale for a cognitive outcome substudy in ischemic stroke patients with high risk of cerebral hemorrhage. J Stroke Cerebrovasc Dis. 2016;25(8):2061–6.

    Article  PubMed  Google Scholar 

  36. Heo SH, Cho AH, Park JH, et al. Effect of probucol on the progression of white matter hyperintensities in ischemic stroke patients with a higher burden of small vessel disease: the PICASSO MRI-substudy. J Neurol Sci. 2017;381:164.

    Article  Google Scholar 

  37. Park SH, Kim JH, Bae SS, et al. Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid beta-induced cognitive deficits associated with decreased amyloid beta accumulation. Biochem Biophys Res Commun. 2011;408(4):602–8.

    Article  CAS  PubMed  Google Scholar 

  38. Sakurai H, Hanyu H, Sato T, et al. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer’s disease and cerebrovascular disease: a pilot study. Geriatr Gerontol Int. 2013;13(1):90–7.

    Article  PubMed  Google Scholar 

  39. Ding M, Fratiglioni L, Johnell K, et al. Atrial fibrillation, antithrombotic treatment, and cognitive aging: a population-based study. Neurology. 2018;91(19):e1732–40.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–63.

    Article  PubMed  Google Scholar 

  41. Gorelick PB, Furie KL, Iadecola C, et al. Defining optimal brain health in adults: a presidential advisory from the American Heart Association/American Stroke Association. Stroke. 2017;48(10):e284–303.

    Article  PubMed  PubMed Central  Google Scholar 

  42. METACOHORTS Consortium. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: an initiative of the joint programme for neurodegenerative disease research. Alzheimers Dement. 2016;12(12):1235–49.

    Article  Google Scholar 

  43. Sachdev PS, Lo JW, Crawford JD, et al. STROKOG (stroke and cognition consortium): an international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease. Alzheimers Dement (Amst). 2017;7:11–23.

    Google Scholar 

  44. Ikram MA, Bersano A, Manso-Calderon R, et al. Genetics of vascular dementia—review from the ICVD working group. BMC Med. 2017;15(1):48.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgment

This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (No.2017R1C1B5018132) and the Hallym University Research Fund (HURF-2017-03).

Author information

Authors and Affiliations

  1. Department of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang-si, Gyeonggi-do, South Korea

    Jae-Sung Lim

Authors
  1. Jae-Sung Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jae-Sung Lim .

Editor information

Editors and Affiliations

  1. Department of Neurology, Seoul National University Hospital, Seoul, Korea (Republic of)

    Seung-Hoon Lee

  2. Department of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute Hallym University College of Medicine, Anyang-si, Gyeonggi-do, Korea (Republic of)

    Jae-Sung Lim

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lim, JS. (2020). Post-stroke Cognitive Impairment. In: Lee, SH., Lim, JS. (eds) Stroke Revisited: Vascular Cognitive Impairment. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1433-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1433-8_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1432-1

  • Online ISBN: 978-981-10-1433-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation